Risk factors include high serum phosphate level with increased calcium phosphate product, secondary hyperparathyroidism, and use of calcium containing phosphate binders, use of calcitriol, diabetes mellitus, obesity, low albumin, Coumadin therapy, female gender, and Caucasian race [2, 5]. The gene discussed is ALB; the disease is obesity due to melanocortin 4 receptor deficiency.